View Report Details Spinal Cord Stimulation Market- 2016 Edition ----------------------------------------2016
View Report Details Executive Summary
Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time.
A chronic back pain can be treated through spinal cord stimulation (SCS) therapy.
SCS therapy is a process that uses soft thin wires with electrical leads to be placed in the spinal column through needle so as to cure chronic back pain.
Spinal Cord Stimulation Therapy doesn’t eliminate the pain; it just interferes with the signals sent to the brain.
The SCS surgery is performed in two stages: trial stimulation and permanent implantation.
Spinal cord stimulation therapy is used to reduce the pain signals that are sent to the brain through spinal cord which in return release pain relief chemicals.
For this process, a spinal cord stimulator also known as dorsal column stimulator, is surgically placed under the skin to send a mild electrical current to the spinal cord.
The spinal cord stimulation (SCS) market is vast and remains relatively untouched with huge potential to treat widespread chronic back pain. The global SCS market is expected to increase in the coming years.
The US has the chronic back pain prevalence with maximum number of addressable population and system implants.
The key factors driving the growth in the SCS market includes increasing adult population in the US, increasing demand for minimally invasive surgeries, innovation of new technologies & therapies, growing cases of obesity, and rise in ageing demographics.
However, there are number of factors which are hindering the growth of the SCS market like high cost associated with therapy, tough regulatory approvals, and major reliance on traditional SCS therapy.
The report offers an in-depth analysis of the spinal cord stimulation market segmented into global SCS and regional SCS market, covering the US and outside the US market.
Competition in this market is rather concentrated with a few medical device companies dominating the market, through innovation.
Medical companies that have been covered in the report include Medtronic Plc., Nevro Corporation, Boston Scientific, and St. Jude Medical.
Spinal Cord Stimulation market is expected to grow significantly in the coming years driven by several factors including increasing demand for minimally invasive therapy, innovation in technology, increasing addressable population… Spinal Cord Stimulation Market by Value (2014-2018E)
The revenue for global spinal cord stimulation market is expected to be recorded at US$.. million by 2018, increasing from US$.. million in the year 2015, recording growth at a CAGR of ..% for the period spanning from 2014-2018. The US which is expected to account for ..% share of the total SCS therapy market in terms of value. Outside the US, is expected to account for nearly ..% share of the market. The global SCS addressable population is expected to reach .. million people by 2020 increasing from ..million people in the year 2015. The global SCS system implants volume is expected to reach ..thousands by 2018, increasing from ..thousands implants in the year 2015.
Global SCS Addressable Population (2014-2018E)
Global SCS System Implants Volume (2014-2018E)
The regional market was driven by increasing chronic back pain prevalence, increased failed back surgeries, and growing number of ageing population.. The US Chronic Back Pain Prevalence (2014-2018E)
The total number of people suffering from chronic back pain in the US is expected to reach ..million by year 2018 increasing from ..million in the year 2015, recording growth at a CAGR ..% for the period spanning from 2014-2018. The US spinal cord stimulation market is expected to be recorded at US$.. million by 2018 increasing from US$.. million in the year 2015, recording a growth at a CAGR of ..% from the period spanning from 2014-2018 The spinal cord stimulation market outside the US is expected to be recorded at US$.. million by 2018 increasing from US$.. million in the year 2015, recording a growth at a CAGR of ..% for the period spanning from 2014-2018.
The US SCS Market by Value (2014-2018E) )
SCS Market Value outside the US (2014-2018E)
The Spinal Cord Stimulation market is concentrated with major medical device companies dominating the market through innovation in technologies & therapies… Global SCS Comparative Market Share (2015/2018E)
XX has ..% of market share for the year 2015 and it is expected to record a fall of ..% in its market share by 2018. XX is expected to record ..% of the market share by 2018 increasing from ..% for the year 2015. In the US by 2015, trial units were recorded at ..thousands, whereas it is expected to reach ..thousands by 2020, growing at a CAGR of ..% for the period spanning from 2015-2020. ..% of respondents chose MRI for SCS devices, whereas ..% of respondents chose Battery life. Other aspects of choosing SCS devices including recharge ability and cost were also considered to be important by ..% and ..% respondents respectively.
Increasing Trial Units in the US (2015-2020E)
Aspects of Choosing SCS Devices (2015)
Contact Us: View Report Details These are abridged and sanitized sample pages from the comprehensive report on the “ Spinal Cord Stimulation Market- 2016 Edition ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com